title: Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Zachariah
authors.forename: Veena
authors.initials: V
authors.lastname: Kumari
authors.forename: Adrian
authors.initials: A
authors.lastname: Galea
authors.forename: Mrigendra
authors.initials: M
authors.lastname: Das
authors.forename: Ravi
authors.initials: R
authors.lastname: Mehrotra
authors.forename: David
authors.initials: D
authors.lastname: Taylor
authors.forename: Manjit
authors.initials: M
authors.lastname: Ruprah
authors.forename: Tonmoy
authors.initials: T
authors.lastname: Sharma
mesh_terms: D000284:Administration, Oral; D000328:Adult; D018680:Cholinergic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D011352:Procyclidine / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D018680:Cholinergic Antagonists; D011352:Procyclidine